SYMBIANT
LIVE

Serial Number

79092663

Owner

Stichting Medisch Centrum Alkmaar

Filing Date

Apr 8, 2010

Add to watchlist:

No watchlists yet
View on USPTO

SYMBIANT Trademark

Serial Number: 79092663 • Registration: 4097633

SYMBIANT is a trademark filed by Stichting Medisch Centrum Alkmaar on April 8, 2010. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

Stichting Medisch Centrum Alkmaar

Wilhelminalaan 12

Entity Type: 98

Stichting Zaans Medisch Centrum

Koningin Julianaplein 58

Entity Type: 99

Trademark Details

Filing Date

April 8, 2010

Registration Date

February 14, 2012

Published for Opposition

November 29, 2011

Cancellation Date

April 9, 2020

Goods & Services

Printed matter, photographs, instructional and teaching material (except apparatus) for the presentation of anatomical and pathological properties and of the chemical, biochemical, physical and physiological processes as part of the evaluation of the safety of drugs (medicines)

Medical services; medical research; medical and diagnostic services related to the safety aspects of drugs (medicines); medical consultancy; services of pathologists; consultancy with regard to the safety and side-effects of drugs (medicines), as well as the carcinogenic properties of drugs (medicines)

Scientific research for medical purposes; analysis and evaluation of the results of pathological and toxicological research for the purpose of, inter alia, the safety aspects of drugs (medicines), as well advice on the results thereof; services of a laboratory; laboratory research, including in the field of microbiology and infectious diseases; medical laboratory research; technical consultancy about the design of interior of laboratories and technical consultancy about the use and application of laboratory equipment; diagnostic tests, identification of the side-effects and carcinogenic properties of drugs (medicines); evaluation of clinical tests; research with regard to the safety and side-effects of drugs (medicines), as well as the carcinogenic properties of drugs (medicines); research relating to risk analyses of risk analyses of drugs (medicines)

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Nov 1, 2020 DENC
DEATH OF INTERNATIONAL REGISTRATION
Nov 1, 2020 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Aug 9, 2019 INNT
GENERIC MADRID TRANSACTION SENT TO IB
Jun 17, 2019 XXSS
GENERIC MADRID TRANSACTION CREATED
Jun 17, 2019 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
May 21, 2019 INTR
CANCELLED SECTION 71
Sep 21, 2018 C71T
NEW REPRESENTATIVE AT IB RECEIVED
May 15, 2015 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Oct 6, 2013 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Sep 21, 2013 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 22, 2012 FINV
NOTIFICATION PROCESSED BY IB
Jul 14, 2012 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jun 28, 2012 FICS
FINAL DISPOSITION PROCESSED
Jun 28, 2012 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 14, 2012 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 14, 2012 R.PR
PUBLISHED FOR OPPOSITION
Nov 29, 2011 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 23, 2011 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 23, 2011 OP2R
NOTICE OF PUBLICATION
Nov 9, 2011 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 27, 2011 PREV
ASSIGNED TO LIE
Oct 26, 2011 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 29, 2011 CNSA
REFUSAL PROCESSED BY IB
Mar 27, 2011 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 3, 2011 RFCS
REFUSAL PROCESSED BY MPU
Mar 3, 2011 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 3, 2011 RFCR
NON-FINAL ACTION WRITTEN
Mar 2, 2011 CNRT
APPLICATION FILING RECEIPT MAILED
Feb 22, 2011 MAFR
ASSIGNED TO EXAMINER
Feb 18, 2011 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 18, 2011 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 17, 2011 REPR